Your browser doesn't support javascript.
loading
Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities.
Lai, Michele; La Rocca, Veronica; Amato, Rachele; Freer, Giulia; Pistello, Mauro.
Afiliación
  • Lai M; Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
  • La Rocca V; Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
  • Amato R; Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
  • Freer G; Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy.
  • Pistello M; Retrovirus Center and Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56127 Pisa, Italy. mauro.pistello@med.unipi.it.
Int J Mol Sci ; 20(14)2019 Jul 12.
Article en En | MEDLINE | ID: mdl-31336922

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Autofagia / Transducción de Señal / Transformación Celular Neoplásica / Ceramidas / Susceptibilidad a Enfermedades / Melanoma Tipo de estudio: Etiology_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingolípidos / Autofagia / Transducción de Señal / Transformación Celular Neoplásica / Ceramidas / Susceptibilidad a Enfermedades / Melanoma Tipo de estudio: Etiology_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Italia